Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/1996
05/15/1996EP0711548A1 Injectable microdispersions for soft tissue repair and augmentation
05/15/1996EP0711540A1 Cosmetic or dermatologic oil/water dispersion stabilized with cubic gel particles and method of preparation
05/15/1996EP0711539A1 Use of a salicylic acid derivative as stabilizer of oil-in-water emulsion, surfactants-free
05/15/1996EP0711181A1 Psoriasis treatment
05/15/1996EP0711177A1 Improvements relating to prodrugs
05/15/1996EP0711154A1 Stabilized pharmaceutical composition containing bupropion
05/15/1996EP0711147A1 Suspensions for delivery of medicament
05/15/1996EP0711142A1 Use of cross-linked copolymers of monoethylenically unsaturated carboxylic acids as stabilizers in oil-in-water emulsions
05/15/1996EP0711140A1 Antifungal nail solution
05/15/1996EP0711127A1 Methods of preparing gas-filled liposomes
05/15/1996EP0682522B1 Process to prepare pharmaceutical compositions containing vecuronium bromide
05/15/1996EP0641194B1 Oil-in-water emulsion containing a perfluoropolyether, composition comprising same, preparation method therefor and cosmeticological and dermatological use thereof
05/15/1996EP0620828A4 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof.
05/15/1996EP0496839B1 Vaccine against drugs of abuse
05/15/1996EP0463114B1 Assay for and treatment of autoimmune diseases
05/15/1996EP0458894B1 Lipid excipient for nasal delivery and topical application
05/15/1996CN1122575A Stable liquid compositions of gamma interferon
05/15/1996CN1122571A High dose formulations
05/15/1996CN1122569A Transdermal therapeutic system containing estradiol
05/15/1996CN1122248A Insulin analog formulations
05/15/1996CN1122247A Vaccine composition for eliciting an immune response against N-glycolylated gangliosides and its use for cancer treatment
05/15/1996CN1122226A Tablet, capsule, or granule comprising desogestrel
05/14/1996US5516810 Metallospheres and superclusters
05/14/1996US5516808 Antibiotic gel
05/14/1996US5516770 Rapamycin formulation for IV injection
05/14/1996US5516766 Proteins adsorbed on cyclodextrins, such as heparin binding growth factor, fibroblast growth factor for polyionic derivatives
05/14/1996US5516673 Preactivation of cellulose, polyvinyl alcohol, or the like with pyridine, pyrrole, pyridazine or their derivatives; further reaction with proteins; wound healing agents
05/14/1996US5516643 Diagnosis
05/14/1996US5516523 Transmucosal delivery of macromolecular drugs
05/14/1996US5516395 Process for the production of collagen foams in the form of continuous tapes and their use in medicine, cosmetics and hygiene
05/14/1996CA2094090C Thixotropic formulations
05/11/1996CA2162520A1 Cosmetic or dermatological compositions as an oily phase dispersed in an aqueous phase stabilized with cubic gel particles and process for producing the same
05/10/1996CA2162342A1 Intravenous solutions for a derivative of staurosporine
05/10/1996CA2162341A1 Pharmaceutical carriers
05/09/1996WO1996013610A2 Methods and reagents for the identification and regulation of senescence-related genes
05/09/1996WO1996013522A1 Complementarily bonded two- and three-dimensional supramolecular structures
05/09/1996WO1996013511A1 Poly-unsaturated carbohydrate derivatives, polymers thereof and their use
05/09/1996WO1996013286A2 Modulation of cell proliferation and wound healing
05/09/1996WO1996013273A1 Pharmaceutical compositions
05/09/1996WO1996013253A1 Biodegradable sustained release preparation for treating periodontitis
05/09/1996WO1996013249A1 Pharmaceutical compositions
05/09/1996WO1996013248A1 Injection-molded dosage form
05/09/1996WO1996013164A1 Polymeric wound healing accelerators
05/09/1996DE4439858A1 Durch Co-Sprühtrocknung erhältliche Polyol-Zusammensetzung Obtainable by co-spray drying polyol composition
05/09/1996DE4439575A1 Pharmaceutical and cosmetic gels, emulsions, creams and films
05/09/1996DE19541333A1 Base coating for solid enteric-coated pharmaceutical
05/09/1996DE19540669A1 Non-parenteral interferon compsn.
05/09/1996DE19539860A1 Oral cyclosporin formulations
05/09/1996CA2513441A1 Pharmaceutical compositions
05/09/1996CA2204020A1 Nucleic acid transfer system
05/09/1996CA2203875A1 Complementarily bonded two- and three-dimensional supramolecular structures
05/09/1996CA2202618A1 Methods and reagents for the identification and regulation of senescence-related genes
05/09/1996CA2199847A1 Poly-unsaturated carbohydrate derivatives, polymers thereof and their use
05/08/1996EP0710723A1 Cloning and expression of a gene encoding bryodin 1 from bryonia dioica
05/08/1996EP0710720A1 Method for the production of monoclonal antibodies utilizing a germfree animal
05/08/1996EP0710689A2 Polymeric antitumor agents
05/08/1996EP0710688A1 Hydroxysilyl-terminated polyoxyethylene compound, quaternary-salt-terminated block copolymer, and percutaneous absorption promoter
05/08/1996EP0710653A1 Salts of nefazodone having improved dissolution rates
05/08/1996EP0710478A1 Composition for topical application containing a lipase and an active agent precursor
05/08/1996EP0710261A1 Biodegradable particles
05/08/1996EP0710244A1 Immunoreactive reagents employing monoamine oxidase
05/08/1996EP0710226A1 Novel organic products containing reactive thiol functions, one method for preparing same, and biomaterials containing said products
05/08/1996EP0710122A1 Stabilized pharmaceutical peptide compositions
05/08/1996EP0710110A1 Rapamycin conjugates and antibodies
05/08/1996EP0710104A1 Pharmaceutical compositions for hardly soluble active substances
05/08/1996EP0710103A1 Pharmaceutical compositions for hardly soluble active substances
05/08/1996EP0710102A1 Stabilization of aerosolized proteins
05/08/1996EP0651634B1 Cross-linked polyhydroxylic material for enzymatically controlled drug release
05/08/1996EP0580648B1 Process for conditioning of water-soluble substances
05/08/1996EP0514506B1 Lipid formulation system
05/08/1996CN1122109A Veterinary composition containing a proton pump inhibitor
05/08/1996CN1122103A Coated pharmaceutical compositions
05/08/1996CN1121807A "Ailing" anticancer injection
05/07/1996US5514794 Antibody-drug conjugates
05/07/1996US5514776 Antiallergen
05/07/1996US5514673 Pharmaceutical composition containing lipophilic drugs
05/07/1996US5514657 Wound healing, silver sulfadiazine, collagen
05/07/1996US5514554 Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy
05/07/1996US5514379 Polyoxyalkylene glycol diacid derivative crosslinking agents
05/07/1996US5514370 High dosage topical forms of collagenase
05/07/1996US5514364 Non-lethal methods for conditioning a recipient for bone marrow transplantation
05/07/1996CA2025317C Thrombolytic composition containing tissue type plasminogen activator or derivative thereof
05/07/1996CA2014157C Antiparasitic formulation containing 25-cyclohexyl-avermectin b1
05/03/1996CA2160423A1 Salts of nefazodone having improved dissolution rates
05/02/1996WO1996012802A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease
05/02/1996WO1996012739A1 Immunomodulatory polypeptides
05/02/1996WO1996012507A1 Antibody reagent for detecting dissecting aortic aneurysm and use thereof
05/02/1996WO1996012504A1 Oil-in-water formulation for topical application
05/02/1996WO1996012495A1 Percutaneously administrable preparation
05/02/1996WO1996012493A1 Absorption enhancer/solubilizer combination for improved bioavailability of a zwitterionic compound
05/02/1996WO1996012475A1 Active agent transport systems
05/02/1996WO1996012474A1 Compositions for the delivery of antigens
05/02/1996WO1996012473A1 Compounds and compositions for delivering active agents
05/02/1996WO1996012472A1 Liposome composition containing selegilin
05/02/1996WO1996012405A1 Method for destroying residual lens epithelial cells
05/02/1996WO1996003151A3 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy
05/02/1996WO1995027732A3 Circularly permuted ligands and circularly permuted chimeric molecules
05/02/1996CA2203504A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease
05/02/1996CA2202299A1 Compositions for the delivery of antigens
05/02/1996CA2161603A1 Polymeric antitumor agents
1 ... 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 ... 1712